Connect with us
In the short term, the early detection test developed by ADmit Therapeutics will make it possible to optimize patient recruitment for clinical trials. People will be...
Moderna's commitment to Spain was made clear last Tuesday, June 7th, when representatives of the US biotech company met with the President of the Government, Pedro...
The works of the future center will begin in June with a gradual demolition of the pre-existing building, on Manuel Ramon street, in front of CosmoCaixa,...
VB Devices closed 2021 with sales of $339,000 (€315,000), the target for 2022 is to achieve $977,000 (€909,000) and for 2023 to exceed $1.6 million (€1.5...
Diets are like the financial equivalent of credit cards and get-rich-quick schemes. At best, they do nothing to fix your short-term problems. At worst, they do...
The company maintains its growth forecasts. By 2022, Moonz expects to earn just over eight million euros, which would double the figure for the year of...
Minoryx Therapeutics, based in Mataró (Barcelona), will also finance the activities necessary to be able to proceed with the approval of leriglitazone in the United States...
Leo Pharma recorded a turnover of $1.44 billion (€1.34 billion) in 2021. The company has a strategic focus on drugs for skin diseases such as atopic...
Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
Of the total amount that Laminar Pharma estimates it needs, $10.7 million (€10 million) correspond to bank financing already agreed with Banca March. In addition, the...
 |
|
 |  |
 |
|